Blaine Pfeifer

Title: Blaine Pfeifer: Innovator in Vaccine Development

Introduction

Blaine Pfeifer is a notable inventor based in Buffalo, NY (US), recognized for her contributions to vaccine development. With a total of 2 patents, she has made significant strides in addressing infectious diseases through innovative vaccine formulations.

Latest Patents

Pfeifer's latest patents include a comprehensive vaccine design aimed at combating commensal disease progression. This patent details vaccine compositions and methods that utilize liposomes containing polysaccharides from various serotypes, with proteins non-covalently attached to the surface. Another significant patent focuses on pneumococcal vaccine formulations, providing immunogenic compositions that include PnCo and/or GlpO polypeptides, which are preferentially expressed during the virulent phase of infections related to streptococcal bacteria. These compositions are designed to elicit immune responses against streptococcal infections.

Career Highlights

Throughout her career, Pfeifer has worked with esteemed institutions such as the State University of New York and Abcombi Biosciences Inc. Her work has been pivotal in advancing the field of immunology and vaccine research.

Collaborations

Pfeifer has collaborated with notable colleagues, including Charles P. Jones and Jonathan Lovell, contributing to her innovative research and development efforts.

Conclusion

Blaine Pfeifer's work in vaccine development showcases her commitment to improving public health through innovative solutions. Her patents reflect her expertise and dedication to combating infectious diseases.